128 related articles for article (PubMed ID: 32928515)
1. Biopharmaceutics classification evaluation for paris saponin VII.
Zhang X; Sun Y; Cheng Y; Ye WL; Zhang BL; Mei QB; Zhou SY
Chin J Nat Med; 2020 Sep; 18(9):714-720. PubMed ID: 32928515
[TBL] [Abstract][Full Text] [Related]
2. Paris saponin VII reverses chemoresistance in breast MCF-7/ADR cells.
Li Y; Sun Y; Tang T; Niu Y; Li X; Xie M; Jin H; Mei Q
J Ethnopharmacol; 2019 Mar; 232():47-54. PubMed ID: 30552993
[TBL] [Abstract][Full Text] [Related]
3. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
Dahan A; Amidon GL
Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
[TBL] [Abstract][Full Text] [Related]
4. Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting.
Dahan A; Amidon GL
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G371-7. PubMed ID: 19541926
[TBL] [Abstract][Full Text] [Related]
5. Biopharmaceutics classification and intestinal absorption of chikusetsusaponin IVa.
Zhang W; Liu H; Liu C
Biopharm Drug Dispos; 2019 Sep; 40(8):276-281. PubMed ID: 31294470
[TBL] [Abstract][Full Text] [Related]
6. Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge.
Yu XY; Lin SG; Zhou ZW; Chen X; Liang J; Liu PQ; Duan W; Chowbay B; Wen JY; Li CG; Zhou SF
Curr Drug Metab; 2007 May; 8(4):325-40. PubMed ID: 17504222
[TBL] [Abstract][Full Text] [Related]
7. MRP2 mediated drug-drug interaction: indomethacin increases sulfasalazine absorption in the small intestine, potentially decreasing its colonic targeting.
Dahan A; Amidon GL
Int J Pharm; 2010 Feb; 386(1-2):216-20. PubMed ID: 19944137
[TBL] [Abstract][Full Text] [Related]
8. Intestinal permeability study of minoxidil: assessment of minoxidil as a high permeability reference drug for biopharmaceutics classification.
Ozawa M; Tsume Y; Zur M; Dahan A; Amidon GL
Mol Pharm; 2015 Jan; 12(1):204-11. PubMed ID: 25423288
[TBL] [Abstract][Full Text] [Related]
9. Biopharmaceutics and Pharmacokinetics of Timosaponin A-III by a Sensitive HPLC-MS/MS Method: Low Bioavailability Resulting from Poor Permeability and Solubility.
Wang HQ; Gong XM; Lan F; Zhang YH; Xia JE; Zhang H; Guo JL; Liu M
Curr Pharm Biotechnol; 2021; 22(5):672-681. PubMed ID: 32634081
[TBL] [Abstract][Full Text] [Related]
10. Paris saponin VII induces cell cycle arrest and apoptosis by regulating Akt/MAPK pathway and inhibition of P-glycoprotein in K562/ADR cells.
Yan T; Hu G; Wang A; Sun X; Yu X; Jia J
Phytother Res; 2018 May; 32(5):898-907. PubMed ID: 29377384
[TBL] [Abstract][Full Text] [Related]
11. Intestinal absorption mechanisms of araloside A in situ single-pass intestinal perfusion and in vitro Caco-2 cell model.
Yang H; Zhai B; Fan Y; Wang J; Sun J; Shi Y; Guo D
Biomed Pharmacother; 2018 Oct; 106():1563-1569. PubMed ID: 30119231
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the intestinal absorption of morroniside from Cornus officinalis Sieb. et Zucc via a Caco-2 cell monolayer model.
Xu R; Zhu H; Hu L; Yu B; Zhan X; Yuan Y; Zhou P
PLoS One; 2020; 15(5):e0227844. PubMed ID: 32470043
[TBL] [Abstract][Full Text] [Related]
13. Paris saponin VII inhibits growth of colorectal cancer cells through Ras signaling pathway.
Li Y; Sun Y; Fan L; Zhang F; Meng J; Han J; Guo X; Zhang D; Zhang R; Yue Z; Mei Q
Biochem Pharmacol; 2014 Mar; 88(2):150-7. PubMed ID: 24462916
[TBL] [Abstract][Full Text] [Related]
14. [Mechanism of oral absorption of panaxnotoginseng saponins].
Han M; Han LM; Wang QS; Bai ZH; Fang XL
Yao Xue Xue Bao; 2006 Jun; 41(6):498-505. PubMed ID: 16927822
[TBL] [Abstract][Full Text] [Related]
15. Quantitative biopharmaceutics classification system: the central role of dose/solubility ratio.
Rinaki E; Valsami G; Macheras P
Pharm Res; 2003 Dec; 20(12):1917-25. PubMed ID: 14725354
[TBL] [Abstract][Full Text] [Related]
16. Transport characteristics of tryptanthrin and its inhibitory effect on P-gp and MRP2 in Caco-2 cells.
Zhu X; Zhang X; Ma G; Yan J; Wang H; Yang Q
J Pharm Pharm Sci; 2011; 14(3):325-35. PubMed ID: 21824448
[TBL] [Abstract][Full Text] [Related]
17. Caco-2 cells and Biopharmaceutics Classification System (BCS) for prediction of transepithelial transport of xenobiotics (model drug: caffeine).
Smetanova L; Stetinova V; Kholova D; Kvetina J; Smetana J; Svoboda Z
Neuro Endocrinol Lett; 2009; 30 Suppl 1():101-5. PubMed ID: 20027153
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of transport and structure-permeability relationship of sulfasalazine and its analogs in Caco-2 cell monolayers.
Liang E; Proudfoot J; Yazdanian M
Pharm Res; 2000 Oct; 17(10):1168-74. PubMed ID: 11145220
[TBL] [Abstract][Full Text] [Related]
19. Potential P-glycoprotein-mediated herb-drug interaction of phyllanthin at the intestinal absorptive barrier.
Dunkoksung W; Vardhanabhuti N; Jianmongkol S
J Pharm Pharmacol; 2019 Feb; 71(2):213-219. PubMed ID: 30251430
[TBL] [Abstract][Full Text] [Related]
20. Studies on pharmacokinetic properties and absorption mechanism of phloretin: In vivo and in vitro.
Zhao YY; Fan Y; Wang M; Wang J; Cheng JX; Zou JB; Zhang XF; Shi YJ; Guo DY
Biomed Pharmacother; 2020 Dec; 132():110809. PubMed ID: 33049584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
